Cencora
Update in progressCOR (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Distribution
Cencora, Inc. sources and distributes pharmaceutical and related health products in the United States and globally. Its U.S. Healthcare Solutions segment provides generic and injectable drugs, OTC products, home care supplies, vaccines, plasma and blood products, and related services to hospitals, pharmacies, clinics, and long‑term care sites; also offers pharmacy management, software, packaging, clinical trial support, data analytics, and vendor services. International Healthcare Solutions covers wholesale, commercialization, and logistics for biopharma. Founded 1871, based in Conshohocken, PA; formerly AmerisourceBergen, renamed in 2023.
Company score
- Sentiment
- 0.52
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.04
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.32
- Governance
- -0.19
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.07
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.30
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
No news articles are available for this company yet.
Unable to load company news.
You're all caught up!